Baoxin software: Baokang electronic Beidou vehicle-mounted positioning terminal has achieved a substantial breakthrough in Beidou application through the certification of the Third Institute of Public Security. Recently, the Beidou vehicle-mounted positioning terminal independently integrated by Baoxin software Baokang Electronics has passed the authoritative certification of the Third Institute of Public Security. The terminal adopts a fully domestic chip, which indicates that Baokang Electronics has made a substantial breakthrough in the Beidou application field and has taken a solid step to expand into new business fields. The terminal is based on a single Beidou chip, and all components are made in China, which can achieve centimeter-level accurate positioning. It has a wide application potential in many fields, such as official vehicle management, iron ore transport vehicle scheduling, steel coil frame transport vehicle positioning, fully automatic torpedo tank car positioning, electric bicycle management and so on.Shanzi Hi-Tech fell 2.28% today, and Shenzhen Stock Connect sold 193 million yuan. Shanzi Hi-Tech fell 2.28% today, with a turnover of 6.38 billion yuan and a turnover rate of 33.13%. After-hours data showed that Shenzhen Stock Connect bought 34.7754 million yuan and sold 228 million yuan.On the analysis of the daily limit at noon on December 11th, the three major indexes rose slightly, and consumer electronics concept stocks broke out collectively. Yiming food has 12 boards, Shandong glass fiber has 6 boards, one picture can be understood > >
The President of Peru called for the restoration of the death penalty for criminals who raped children, and the President of Peru Dina Ersilia Brou Art segala called for the restoration of the death penalty for criminals who raped children on the 10th. Earlier, a 12-year-old girl in the capital Lima was killed after being suspected of sexual assault. (Xinhua News Agency)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.
Celeste's new patent can be used for early warning of safe driving according to sitting posture. Tianyuecha's intellectual property information shows that recently, the patent of "vehicle driving early warning method, device, electronic equipment and storage medium" applied by Celeste Automobile Co., Ltd. was announced. The method includes: collecting the sitting image of the vehicle driver, identifying the key points in the sitting image, using waist key points and shoulder key points to determine the current sitting centroid, comparing the current sitting centroid with the initial sitting centroid, generating a centroid deviation result, detecting whether the vehicle driver's sitting posture is abnormal according to the centroid deviation result, and giving an early warning prompt to the vehicle driver in response to determining that the vehicle driver's sitting posture is abnormal. According to the invention, the key points of the driver's waist and shoulders are intelligently detected through the sitting posture image to obtain the position of the triangle centroid of the driver's shoulder and waist, and the sitting posture is judged by adopting the sitting posture centroid, so that whether the driver's sitting posture is abnormal can be quickly and accurately recognized, the accuracy of judging the driving sitting posture is improved, the driving warning is automatically performed, and the effectiveness of safe driving of vehicles is ensured.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.A court in Hong Kong dismissed the liquidation case against Territorial Holdings, and a court in Hong Kong dismissed the liquidation case after the petition against Territorial Holdings, a real estate developer in China, was revoked. Our headquarters finance group withdrew the petition, and the debts and expenses have been settled. The liquidation petition was filed in September, involving an outstanding sum of HK$ 275,633.29. (Interface News)
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14